Comparison · NCT01290614-e219f7c6
Pharmacist Intervention vs Control - Usual Care: Number of Participants With PTH Measurement During the Study Period
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Pharmacist Intervention vs Control - Usual Care: Number of Participants With PTH Measurement During the Study Period. Trial comparisons, record NCT01290614-e219f7c6. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01290614-e219f7c6
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.469 | 0.439 | 0.499 | wilson | |
| Risk in group 2 | 0.161 | 0.141 | 0.184 | wilson | |
| Risk difference, group 1 minus group 2 | 0.308 | 0.271 | 0.344 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 2.91 | 2.51 | 3.37 | log | |
| Odds ratio, group 1 over group 2 | 4.6 | 3.77 | 5.61 | log | |
| Number needed to treat, for one more participant with the outcome on Pharmacist Intervention than on Control - Usual Care | 3.25 | 2.91 | 3.7 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: usual care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Pharmacist Intervention | Pharmacist based QI program: Per a study protocol, the pharmacist will call each subject (who has not opted out) and discuss their CKD. In brief, the pharmacist will introduce themselves, ask the subject if they have time to discuss their medical care, inform the subject that they have CKD, briefly discuss CKD, ask the subject if they can come for labs, discuss hypertension management as appropriate, and answer any questions. In addition, for subjects with poorly controlled hypertension, the study pharmacist will arrange for a nutrition consult for a low sodium diet, a mainstay of hypertension management in patients with CKD. Finally, for patients with advanced CKD (GFR \<30 mL/min per 1.73 m2) who are not seeing a nephrologist, the study pharmacist will arrange for a nephrology outpatient appointment to assess the need for placement of access for renal replacement therapy. | 502 | 1,070 | OG000 |
| Group 2 | Control - Usual Care | Patients assigned to control will continue to receive care from their VA provider.~Usual Care: Patients in the control arm will continue to receive usual care from their VA providers. | 182 | 1,129 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants With PTH Measurement During the Study Period
- Description
- The primary process outcome was measurement of PTH during the study period.
- Time frame
- one year
- Population
Source ClinicalTrials.gov
Trial
- Title
- A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD)
- NCT number
- NCT01290614
- Phases
- PHASE4
- Conditions
- Chronic Kidney Disease
- Interventions
- Pharmacist based QI program, Usual Care
- Lead sponsor
- University of Minnesota
- Results first posted
- 2015-07-13
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01290614?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01290614-e219f7c6